Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00766987 : Cardiac FDG PET Viability Registry
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Patients with ischemic left ventricular dysfunction in the moderate to severe range
(previous assessment of ventricular function with left ventricular ejection fraction
(LVEF) approximately 35%

- Patients will be possible candidates for revascularization if sufficient viable
myocardium is identified or considered for heart transplantation if there is no
viable myocardium

- Patients with New York Heart Association (NYHA) or Canadian Cardiovascular Society
(CCS) Class II - IV symptoms despite maximal medical therapy.

Exclusion Criteria:

- Under 18 years of age

- Pregnant or lactating females

- Already known to be ineligible for further revascularization or cardiac

- Unable to lie supine for imaging with PET

- Unable to take insulin (eg. severe hypokalemia)

- Failure to obtain informed consent

- Claustrophobia.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557